ECTS
120 credits
Duration
2 years
Training structure
Faculty of Pharmacy
Language(s) of instruction
French
Presentation
With close links to internationally recognized research institutes (IBMM, IRCM, IRMB, etc.), this program provides the skills and knowledge needed for a career at the Chemistry-Biology-Health interface. The program will provide cutting-edge expertise in chemistry applied to the development of innovative therapies.
Objectives
Design and implementation of cutting-edge start-up chemistry applied to the development of innovative therapies
Know-how and skills
- Design and develop chemical tools for exploring living organisms (probes, molecular agents and/or nano-objects for targeting and vectorization, bioconjugates).
- Design molecules, therapeutic and diagnostic systems, and immunoconjugates with a view to innovation and commercial development in healthcare.
- Developing new therapeutic approaches and biotherapies
- Adding value to research results
- Manage and lead interdisciplinary projects at the interface between chemistry and biology.
Organization
Knowledge control
Program
Select a program
M1 Drug Science and Health Products (P6)
Core UEs
15 creditsThéra and Pharmaco Chemistry
5 creditsToxicological investigation
5 creditsChoice 1
Your choice: 1 of 2
Structural Biology
5 creditsAnalytical techniques for drug quality control
5 credits
Drug design: Introduction to drug design
5 creditsPharmacokinetics, pharmacodynamics and biopharmacy
5 creditsCHOICE 2 UEs
15 creditsChoice of 2 or 3 from 7
Pharmacokinetics, pharmacodynamics and biopharmacy
5 creditsAdvanced analysis techniques for Medi development.
5 creditsIntroduction to aging and anti-aging
5 creditsCorporate knowledge and patent valuation
5 creditsDrug design: Introduction to drug design
5 creditsMicroscopies and spectroscopies for biology
Industrial development of aging models
5 credits
Long course
15 creditsInternship
10 creditsTER Innovation in Health Chemistry pathway
5 credits
M2 Innovation in Health Chemistry and Therapeutic Targeting
Specific courses
Drug design: case studies
2 creditsTargeted therapies
2 creditsModeling molecule-target therapeutic interactions 1
2 creditsImmunotargeting
2 creditsModeling molecule-target therapeutic interactions 2
2 creditsTherapeutic peptides § Peptidomimetics
Chemobiology (67% ENSCM)
2 creditsStructure-based drug design
2 creditsNanotechnologies for health (UE PHARMACIE)
2 creditsTissue engineering and cell therapy
2 credits
Core syllabus
Admission
Admission requirements
For Master 1: Hold a L3 degree (general or professional bachelor's degree, BUT, etc.) in chemistry or at the chemistry-biology interface.
For Master 2: hold a Master 1 in drug sciences, health products or chemistry. Be a pharmacist, doctor or veterinary surgeon, or be a student who has validated his/her DFASP2 or DFASM3, or be a pharmacy or medical intern.